Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
{{output}}
Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated 50% mortality in early infancy, we immediately began to develop a customized ... ...
